An overview on small molecules acting as broad-spectrum agents for yellow fever infection
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - June 24, 2022 Category: Drugs & Pharmacology Authors: Jenny Desantis Tommaso Felicetti Rolando Cannalire Source Type: research
Targeting the adrenomedullin-2 receptor for the discovery and development of novel anti-cancer agents
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - June 23, 2022 Category: Drugs & Pharmacology Authors: Ameera B. A. Jailani Kamilla J. A. Bigos Paris Avgoustou Joseph L. Egan Robert A. Hathway Timothy M. Skerry Gareth O. Richards Source Type: research
Can artificial intelligence accelerate preclinical drug discovery and precision medicine?
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - June 20, 2022 Category: Drugs & Pharmacology Authors: Ali Farnoud Alexander J. Ohnmacht Martin Meinel Michael P. Menden Source Type: research
Maximizing the integration of virtual and experimental screening in hit discovery
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - June 15, 2022 Category: Drugs & Pharmacology Authors: D ávid Bajusz Gy örgy M Keserű Source Type: research
Unmasking allosteric-binding sites: novel targets for GPCR drug discovery
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - June 13, 2022 Category: Drugs & Pharmacology Authors: Ver ònica Casadó-Anguera Vicent Casad ó Source Type: research
Identifying novel drugs with new modes of action for neglected tropical fungal skin diseases (fungal skinNTDs) using an Open Source Drug discovery approach
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - June 10, 2022 Category: Drugs & Pharmacology Authors: Wilson Lim Annelies Verbon Wendy van de Sande Source Type: research
PTPN22: structure, function, and developments in inhibitor discovery with applications for immunotherapy
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - June 8, 2022 Category: Drugs & Pharmacology Authors: Brenson A. Jassim Jianping Lin Zhong-Yin Zhang Source Type: research
A meditation on accelerating the development of small molecule medicines targeting RNA
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - June 6, 2022 Category: Drugs & Pharmacology Authors: Xueyi Yang Jessica L. Childs-Disney Matthew D. Disney Source Type: research
Approaches for enhancing the analysis of chemical space for drug discovery
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - June 6, 2022 Category: Drugs & Pharmacology Authors: Fernanda I. Sald ívar-González Jos é L. Medina-Franco Source Type: research
A meditation on accelerating the development of small molecule medicines targeting RNA
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - June 6, 2022 Category: Drugs & Pharmacology Authors: Xueyi Yang Jessica L. Childs-Disney Matthew D. Disney Source Type: research
The emerging potential of interactive virtual reality in drug discovery
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - June 2, 2022 Category: Drugs & Pharmacology Authors: Rebecca K. Walters Ella M. Gale Jonathan Barnoud David R. Glowacki Adrian J. Mulholland Source Type: research
Acoustic ejection mass spectrometry: fundamentals and applications in high-throughput drug discovery
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - June 1, 2022 Category: Drugs & Pharmacology Authors: Chang Liu Source Type: research
Pediatric neuropsychiatric syndromes associated with infection and microbiome alterations: clinical findings, possible role of the mucosal epithelium, and strategies for the development of new animal models
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - May 31, 2022 Category: Drugs & Pharmacology Authors: Kurt Leroy Hoffman Hugo Cano-Ram írez Source Type: research
Approaches for targeting the mycobactin biosynthesis pathway for novel anti-tubercular drug discovery: where we stand
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - May 30, 2022 Category: Drugs & Pharmacology Authors: Mousumi Shyam Deepak Shilkar Gourav Rakshit Venkatesan Jayaprakash Source Type: research
Advances in nanotechnology-based platforms for survivin-targeted drug discovery
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - May 24, 2022 Category: Drugs & Pharmacology Authors: Rosemol George Stephanie Hehlgans Maximillian Fleischmann Claus R ödel Emmanouil Fokas Franz R ödel Source Type: research
